Direkt zum Inhalt
Merck

H6041

Sigma-Aldrich

Interferon α 2A human

IFN-α 2A, recombinant, expressed in HEK 293 cells, HumanKine®, suitable for cell culture

Synonym(e):

α 2A Interferon, Human Interferon α 2A, IFN-α 2A

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
12352202
NACRES:
NA.77

Biologische Quelle

human

Rekombinant

expressed in HEK 293 cells

Assay

≥95% (SDS-PAGE)

Form

lyophilized powder

Wirksamkeit

≤0.4 ng/mL EC50

Qualität

endotoxin tested

Mol-Gew.

monomer 16 kDa (glycosylated)

Verpackung

glass bottle of 10 μg (in glass bottle)

Hersteller/Markenname

HumanZyme

Methode(n)

cell culture | mammalian: suitable

Verunreinigungen

≤1EU/mg

UniProt-Hinterlegungsnummer

Lagertemp.

−20°C

Angaben zum Gen

human ... IFNA2(3440)

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

The IFNA2 (interferon alpha 2) gene is mapped to human chromosome 9p21.3. It is considered to be a prototypic type I IFN subtype. The encoded protein contains 165 amino acid. Ifna2 protein structure possesses five α-helices, linked by two disulfide bonds.

Anwendung

Interferon α 2A human has been used to check its antiviral action against chikungunya virus. It has also been used as a control to check the antiviral cytokine induction of Korean red ginseng.

Biochem./physiol. Wirkung

IFNA2 is a type 1 interferon which acts as the first line of defense, and offers protection against pathogenic invasion.
Interferon α 2A (IFN-α 2A) belongs to the type I interferon protein family and is produced by many cell types in response to viral infection. It has antiproliferative and antitumor activities, as well as induction of apoptosis and the inflammatory response. IFN-α 2A enhances the expression of MHC proteins by increasing the presentation of antigen peptides and activates cytotoxic T cells.

Physikalische Form

Lyophilized from a 0.2 μm filtered solution of 1x PBS.

Angaben zur Herstellung

HumanKine IFN-α 2A, expressed in human HEK 293 cells, is a glycosylated monomer with an apparent molecular mass of 16 kDa. Production in human HEK 293 cells offers authentic glycosylation. Glycosylation contributes to stability in cell growth media and other applications.

Hinweis zur Analyse

The activity is determined by the dose-dependent cytotoxicity of the human TF-1 cell line (human erythroleukemic indicator cell line)) ≤ 0.4.

Rechtliche Hinweise

HumanKine is a registered trademark of Proteintech Group, Inc. and Humanzyme, Inc

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

IFNA2: The prototypic human alpha interferon
Paul F, et al.
Gene, 567(2), 132-137 (2015)
Loss of tumor suppressive microRNA-31 enhances TRADD/NF-kappaB signaling in glioblastoma
Rajbhandari R, et al.
Testing, 6(19), 17805-17805 (2015)
Evaluation of broad-spectrum antiviral compounds against chikungunya infection using a phenotypic screening strategy
Bonotto RM, et al.
F1000Research, 7 (2018)
A R Mire-Sluis et al.
Journal of immunological methods, 195(1-2), 55-61 (1996-09-09)
Interferons-alpha and -beta (IFN-alpha and -beta) are cytokines that are widely known to induce potent anti-viral activity. However, it has become increasingly apparent that IFN-alpha and -beta exert a variety of other biological effects, including anti-tumour and immunomodulatory activities and
Gillian M Keating
Drugs, 69(18), 2633-2660 (2009-12-01)
Peginterferon-alpha-2a (40 kD) [Pegasys] comprises an inert, branched, 40 kD polyethylene glycol (PEG) moiety attached to interferon-alpha-2a. Subcutaneous peginterferon-alpha-2a (40 kD) is indicated for the treatment of adults with hepatitis B e antigen (HBeAg)-positive or -negative chronic hepatitis B who

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.